Mikajaki
MIKAJAKI, founded in 2018 and based in Geneva, Switzerland, is a private company revolutionizing ophthalmic diagnostics with its EyeLib™ platform. EyeLib™ is the first fully automated eye health platform combining AI, robotics, and digital technologies to support medical doctors in diagnosing and treating eye conditions. The platform automates the pre-diagnostic process, providing fast, accurate, and reliable ocular analysis, enabling quicker patient access to appropriate treatments and reducing inefficiencies in eye care. MIKAJAKI's business model involves partnering with ophthalmic clinic groups globally to test and implement EyeLib™, supported by Innosuisse and FONGIT Innovation Incubator. The company has received CE marking for EyeLib™, ISO 13485:2016 certification, and multiple awards, positioning it as a top global ophthalmology startup with growing traction and industry recognition.
Mikajaki
MIKAJAKI, founded in 2018 and based in Geneva, Switzerland, is a private company revolutionizing ophthalmic diagnostics with its EyeLib™ platform. EyeLib™ is the first fully automated eye health platform combining AI, robotics, and digital technologies to support medical doctors in diagnosing and treating eye conditions. The platform automates the pre-diagnostic process, providing fast, accurate, and reliable ocular analysis, enabling quicker patient access to appropriate treatments and reducing inefficiencies in eye care. MIKAJAKI's business model involves partnering with ophthalmic clinic groups globally to test and implement EyeLib™, supported by Innosuisse and FONGIT Innovation Incubator. The company has received CE marking for EyeLib™, ISO 13485:2016 certification, and multiple awards, positioning it as a top global ophthalmology startup with growing traction and industry recognition.
TL;DR
Product: EyeLib™ — automated AI + robotics ocular diagnostics platform (Station, Smartbot, SmartVision Report)
Founded / HQ: 2018 (founded) — Geneva, Switzerland
Funding (announced): Pre-Series A / Seed: > CHF 2.4M (May 2020), lead investor BlueOcean Ventures
Regulatory / Quality: CE marking and ISO 13485:2016 certification
Team size (reported): 7 employees
Company Overview
Problem Domain
Ophthalmic diagnostics and patient triage for clinics and hospitals.
Founded
2018
Industry
Medtech / Ophthalmology
Funding Track Record
over CHF 2.4M (shares and convertible loans)
Announced to support CE certification, regulatory completion and initial deployments
Investor Signal
“Lead investor BlueOcean Ventures; participation from a consortium of private ophthalmologist investors; BlueOcean partner Faris Sabeti identified as board observer”